Visionable Appoints First CCO Following Rapid Growth in 2020

VisionableBritish health technology company Visionable has announced the appointment of David Walker to the newly created position of Chief Commercial Officer (CCO), effective immediately. Visionable redesigns healthcare through a digital collaboration platform which enables clinicians to deliver better patient outcomes.

The expansion of the business’ Executive Leadership team follows Visionable’s rapid growth in 2020, which saw £17 million of investment that the company raised in Series A and Series A1 funding rounds.

Visionable has appointed Walker to capitalise on its existing success. The company’s first CCO, Walker will be responsible for developing and creating new partnerships with international organisations to expand Visionable's presence in thriving markets. He will also be identifying new markets where the company’s technology can make huge differences to current practices and efficiencies, also overseeing the expansion of the team as Visionable grows.

Walker has leadership experience in a range of industries, having held senior commercial roles at Sky Television, Dyson, fintech Neyber, and most recently as CCO of AI based technology company Winnow. His experience in creating compelling propositions from innovative products places him in a unique position to understand and deliver on Visionable's current offering and messaging.

Commenting on his new appointment, David Walker said, "I was drawn to Visionable because of the company’s clear dedication to its mission to make healthcare more equitable and accessible for all and its proposition that is changing healthcare as we know it: creating advanced, efficient systems that deliver better outcomes for both patients and professionals."

"Visionable is at an exciting phase of its development, experiencing exceptional demand, poised to scale up and with patented and unique technology to support its vision. I'm delighted to join the Visionable team and be involved in this next stage of the company's growth."

CEO and co-founder of Visionable, Alan Lowe, said, "David has proved his ability, throughout a stellar career, to boost a company’s market share by selling value rather than price, a principle that is intrinsic to Visionable. I’m delighted to welcome David as CCO to our expanding executive team and look forward to working closely with him as we forge partnerships and enter new markets to improve equity in healthcare and deliver better patient outcomes."

About Visionable

Visionable is a healthcare technology company, established in 2015, that provides a digital collaboration platform for clinicians to deliver better patient care. Designed by founders who have worked within the NHS and who continue to partner closely with NHS clinicians, the platform has been created to develop fit-for-purpose digital care pathways and virtual care consultations. Used by NHS hospitals and Trusts, Visionable has delivered and improved patient flow, facilitated quicker decision making and improved patient experience across multiple care settings and specialities such as stroke. This extends to patient consultations, remote diagnostics, telehealth solutions, multidisciplinary teams, virtual visits, and critical patient services.

Most Popular Now

Early Warning System for Intensive Care …

Life-threatening situations occur time and again in an intensive care unit. To make sure that doctors can intervene in time, a team at the German Heart Center Berlin (DHZB) has...

Philips Partners with Orbita to Develop …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Orbita Inc., an innovative provider of conversational artificial intelligence (AI) solutions for healthcare, announced a partnership agreement...

CliniSys Group Creates Single Brand for …

CliniSys Group has created a single brand for its businesses in the UK and Europe, with a refreshed logo and a new website. The move creates a unified identity for CliniSys...

East Lancashire Signs Deal for Early War…

Thousands of NHS professionals across five hospitals in East Lancashire are to benefit from early warning technology that will help them detect and swiftly respond to deteriorating patients in need...

FDA Grants Oxehealth Vital Signs De Novo…

Oxehealth has announced another world first after the US Food and Drug Administration granted a De Novo clearance for its Oxehealth Vital Signs product, which is incorporated into Oxevision, the...

Telemedicine Improves Access to High-Qua…

The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition...

Philips and NHS Implement the First Regi…

Royal Philips (NYSE: PHG, AEX: PHIA), announced it has supported the NHS' Cheshire and Merseyside consortium [1] to become the first regional hub supplying the United Kingdom's National COVID-19 Chest...

AI could Crack the Language of Cancer an…

Powerful algorithms used by Netflix, Amazon and Facebook can 'predict' the biological language of cancer and neurodegenerative diseases like Alzheimer's, scientists have found.

DMEA 2021: Digital Health. 100 % Virtual…

7 - 11 June 2021, Berlin, Germany. An entire week dominated by digital healthcare! With that in mind, early in June DMEA 2021 will be kicking off with a wide range...

X-Rays Combined with AI Offer Fast Diagn…

X-rays, first used clinically in the late 1890s, could be a leading-edge diagnostic tool for COVID-19 patients with the help of artificial intelligence, according to a team of researchers in...

Predicting COVID-19 Outbreaks with Cell …

Mobility tracking using cell phone data showing greater movement of people is a strong predictor of increased rates of COVID-19, according to new data in CMAJ (Canadian Medical Association Journal).